Arshad Kaleem, MD
Oral and Maxillofacial Surgery · El Paso, TXNPI 1134380959
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (37.2%), speaking fees and grants — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Axogen at 43.4% of the total. Reporting peaked in 2019 at $10,931 and has fallen 94.5% since, to $604 in 2025. Among oral and maxillofacial surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 100 payments — averaging $169.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$7K
- Kls-martin L.p.$6K
- Inspire Medical Systems, Inc.$1K
- Johnson & Johnson$788
- Stryker$691
- Straumann USA LLC$249
- plus $796 from 13 others
Across 9 payments — averaging $2842.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Axogen$26K
What the payments were for
- Speaking & faculty fees$4,72528%
- Grants$3,75222%
- Travel & lodging$2,08512%
- Food & beverage$6,28537%
- Education$580%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 25 | $7,332 |
| Kls-martin L.p. | 18 | $5,843 |
| Inspire Medical Systems, Inc. | 11 | $1,206 |
| Johnson & Johnson(2 entities) | 12 | $788 |
| Stryker | 7 | $691 |
| Straumann USA LLC | 6 | $249 |
| AbbVie | 3 | $202 |
| Ambu Inc. | 5 | $119 |
| Polynovo North America LLC | 1 | $92 |
| Atos Medical Inc | 2 | $83 |
| Kerecis Limited | 1 | $65 |
| Medical Device Business Services, Inc. | 1 | $44 |
| Medtronic | 1 | $40 |
| AstraZeneca | 2 | $35 |
| Gilead | 1 | $30 |
| Bayer | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Tolmar, Inc. | 1 | $19 |
| Tempus AI, Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AxoGuard Nerve Connector$6,061
- AxoGuard Nerve Protector$6,061
- Inspire$1,014
- AVANCE NERVE GRAFT$1,003
- NA$457
- TRUMATCH$323
- MEDICAL MODELS$139
- AXOGUARD HA+ NERVE PROTECTOR$110
- AxoGuard Nerve Cap$110
- UBRELVY$100
How this compares
$16,905 in reported general payments places this provider in the 95th percentile of 591 oral and maxillofacial surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 16 | $484 |
| Pentoxifylline | 11 | $350 |
| Chlorhexidine Gluconate | 60 | $223 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $172 |
| Ibuprofen | 16 | $103 |
| Amoxicillin | 14 | $66 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in El Paso
- Vernon BurkeEl Paso$19K
- Nguyen LamEl Paso$8K
- David YatesEl Paso$8K
- James MelvilleHouston$239K
- Pedro FrancoIrving$91K
- Fayette WilliamsFort Worth$74K
- Craig BuchmannKeller$69K
- John ZunigaDallas$61K
- David AlfiHouston$58K
- Herman KaoFort Worth$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.